Literature DB >> 11040356

Wogonin inhibits inducible prostaglandin E(2) production in macrophages.

I Wakabayashi1, K Yasui.   

Abstract

Effects of 5,7-dihydroxy-8-methoxyflavone (wogonin) on cyclooxygenase-2 (COX-2)-mediated prostaglandin E(2) production in macrophages were investigated. Stimulation with lipopolysaccharide (LPS; 1 microg/ml) greatly increased prostaglandin E(2) production in RAW 264.7 murine macrophages. The stimulated prostaglandin E(2) production was abolished in the presence of indomethacin (1 microM) or cycloheximide (2 microM), suggesting that the increased production of prostaglandin E(2) by LPS reflects the inducible synthesis of prostaglandin E(2) by COX-2. Wogonin (0.1-50 microM) concentration-dependently inhibited inducible prostaglandin E(2) production. Wogonin at concentrations as low as 0.5 microM directly attenuated enzymatic activity of COX-2. The protein expression of COX-2 was depressed by wogonin at concentrations of 10 microM and more. These results suggest that wogonin decreases inducible prostaglandin E(2) production in macrophages by inhibiting both COX-2 activity and COX-2 expression. The former action requires much lower doses of wogonin. These wogonin actions may explain, in part, its anti-inflammatory action.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11040356     DOI: 10.1016/s0014-2999(00)00695-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-κB pathway in vitro.

Authors:  Wenping Wang; Tingsong Xia; Xinpu Yu
Journal:  Inflamm Res       Date:  2015-04-28       Impact factor: 4.575

Review 2.  Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease.

Authors:  Ana García-Lafuente; Eva Guillamón; Ana Villares; Mauricio A Rostagno; José Alfredo Martínez
Journal:  Inflamm Res       Date:  2009-04-21       Impact factor: 4.575

3.  Wogonin improves functional neuroprotection for acute cerebral ischemia in rats by promoting angiogenesis via TGF-β1.

Authors:  Zhaohong Kong; Qinglin Shen; Jian Jiang; Min Deng; Zhaohui Zhang; Gaohua Wang
Journal:  Ann Transl Med       Date:  2019-11

4.  Wogonin improves histological and functional outcomes, and reduces activation of TLR4/NF-κB signaling after experimental traumatic brain injury.

Authors:  Chien-Cheng Chen; Tai-Ho Hung; Yen-Ho Wang; Chii-Wann Lin; Pei-Yi Wang; Chun-Yen Lee; Szu-Fu Chen
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

Review 5.  The Therapeutic Potential of Wogonin Observed in Preclinical Studies.

Authors:  Javad Sharifi-Rad; Jesús Herrera-Bravo; Luis A Salazar; Shabnum Shaheen; Seyed Abdulmajid Ayatollahi; Farzad Kobarfard; Muhammad Imran; Ali Imran; Luísa Custódio; María Dolores López; Mauricio Schoebitz; Miquel Martorell; Manoj Kumar; Hafiz Ansar Rasul Suleria; William C Cho
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-15       Impact factor: 2.629

6.  Wogonin induces reactive oxygen species production and cell apoptosis in human glioma cancer cells.

Authors:  Cheng-Fang Tsai; Wei-Lan Yeh; Ssu Ming Huang; Tzu-Wei Tan; Dah-Yuu Lu
Journal:  Int J Mol Sci       Date:  2012-08-08       Impact factor: 6.208

7.  Food Polyphenols Fail to Cause a Biologically Relevant Reduction of COX-2 Activity.

Authors:  Ina Willenberg; Anna K Meschede; Faikah Gueler; Mi-Sun Jang; Nelli Shushakova; Nils Helge Schebb
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

Review 8.  Pharmacological effects of active compounds on neurodegenerative disease with gastrodia and uncaria decoction, a commonly used poststroke decoction.

Authors:  Stanley C C Chik; Terry C T Or; D Luo; Cindy L H Yang; Allan S Y Lau
Journal:  ScientificWorldJournal       Date:  2013-11-14

9.  Wogonin attenuates ovalbumin antigen-induced neutrophilic airway inflammation by inhibiting th17 differentiation.

Authors:  Rie Takagi; Masaaki Kawano; Kazuyuki Nakagome; Kumiko Hashimoto; Takehiro Higashi; Katsuya Ohbuchi; Atsushi Kaneko; Sho Matsushita
Journal:  Int J Inflam       Date:  2014-05-28

10.  Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis.

Authors:  Toru Aoyama; Kazuhiro Nishikawa; Nobuhiro Takiguchi; Kazuaki Tanabe; Motohiro Imano; Ryoji Fukushima; Junichi Sakamoto; Mari S Oba; Satoshi Morita; Toru Kono; Akira Tsuburaya
Journal:  Cancer Chemother Pharmacol       Date:  2014-03-21       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.